株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

血糖モニタリングシステムの世界市場予測

GLOBAL GLUCOSE MONITORING SYSTEM (CGMS & SMBG) MARKET FORECAST 2017-2025

発行 Inkwood Research 商品コード 492797
出版日 ページ情報 英文 160 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=113.53円で換算しております。
Back to Top
血糖モニタリングシステムの世界市場予測 GLOBAL GLUCOSE MONITORING SYSTEM (CGMS & SMBG) MARKET FORECAST 2017-2025
出版日: 2017年08月16日 ページ情報: 英文 160 Pages
概要

当レポートでは、血糖モニタリングシステムの世界市場について調査し、市場構造、市場成長の促進・阻害要因の分析、持続血糖測定システム(CGMS)および血糖自己測定(SMBG)のコンポーネント・用途別の市場動向、競合環境、主要企業のプロファイルなどをまとめています。

第1章 調査範囲

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

  • 市場促進要因とその影響
  • 市場阻害要因とその影響

第5章 持続血糖測定システム(CGMS)市場:コンポーネント別

  • センサー
  • 送受信機
  • インスリンポンプ

第6章 持続血糖測定システム(CGMS)市場:用途別

  • 診療所
  • 病院
  • 在宅医療

第7章 血糖自己測定(SMBG)市場:コンポーネント別

  • 試験紙
  • 血糖値計
  • その他

第8章 血糖自己測定(SMBG)市場:用途別

  • 在宅医療
  • 診療所
  • 病院

第9章 市場分析

  • ファイブフォース分析
  • 市場動向
  • 主要地域
  • 合併・買収
  • 主要動向

第10章 地域分析

  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第11章 競合環境

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: 2229

KEY FINDINGS

The global glucose monitoring system market is separated into continuous glucose monitoring market (CGMS) and self-monitoring of blood glucose (SMBG) market. The CGMS market is anticipated to grow $ 13672 million by 2025. The SMBG market is expected to grow from $12481 million in 2016 to $20563 million by 2025., at a CAGR of 36.72% between 2016 and 2025. The base year considered for the market study is 2016 and the forecast period is between 2017 and 2025. The (CGM) continuous glucose monitoring device is system practiced to measure glucose levels in the interstitial fluid that commence between the skin cells and display in the monitor. (SMBG) Self-monitoring of blood glucose is to supervise glucose level.

MARKET INSIGHTS

The continuous glucose monitoring system and self-monitoring blood glucose is segmented into component type, application, and geography. The CGMS market by component type is segmented into sensors, transmitters, receivers, and insulin pump. The application segmented of CGMS is further segmented into diagnostics and clinics, hospitals, and home settings. The SMBG market by the component is segmented into test strips, glucose meter, and others. The application segmented of SMBG is further bifurcated into home settings, clinics, and hospitals. The geography market is segmented into North America, Europe, Asia-Pacific, Latin America and rest of the world. Rise in Diabetic Population, growth in Healthcare Expenditure, high Focus on Research and Development, Technology Integration, Increase in the CGMS Affordability, and less Price of Technology are the major drivers for the Glucose monitoring market.

REGIONAL INSIGHTS

The CGMS and SMBG market in North America is anticipated to hold the largest share by 2025 whereas in both CGMS and SMBG market Asia Pacific is expected to be the fastest growing region with a CAGR of 48.72% and 11.22% during the forecast period. North America is a highly developed market for CGMS and SMBG with over 3 million of Type 1 Diabetes (T1D). The US is the largest market for the current CGMS. There are about 60 million diabetics in Europe. In 2016, Europe CGMS market accounted for $83 million and estimated to witness a CAGR of 41.72% during the forecast period. The SMBG market is accounted for $1180 million and anticipated to witness a CAGR of 8.14% during the forecast period. Asia Pacific is anticipated to be the fastest growing region in the CGMS and SMBG market. Increasing prevalence rate of diabetes in India and China are creating significant opportunities for continuous glucose monitoring system in the region. In 2015, more than 200 million people in Asia are already suffering from diabetes and the number is estimated to exceed 300 million by 2030.

COMPETETIVE INSIGHTS

Major players for the Glucose monitoring market are Dexcom, Johnson and Johnson, Tandem diabetes, Roche diagnostics, Nemaura medical Inc., Senseonics, Glysens incorporated Medtronic, Abbott, Insulet corp., and Echo therapeutics.

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF THE MARKET
  • 1.3. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
  • 2.2. BOTTOM-UP APPROACH
  • 2.3. TOP DOWN APPROACH
  • 2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY & KEY FINDINGS OF THE STUDY

4. MARKET OVERVIEW

  • 4.1. DRIVERS AND IMPACT
    • 4.1.1. INCREASE IN DIABETIC POPULATION
    • 4.1.2. INCREASE IN HEALTHCARE EXPENDITURE
    • 4.1.3. INCREASING FOCUS ON RESEARCH AND DEVELOPMENT
    • 4.1.4. TECHNOLOGY INTEGRATION
    • 4.1.5. INCREASING CGMS AFFORDABILITY
    • 4.1.6. LOW PRICE OF TECHNOLOGY
  • 4.2. RESTRAIN AND IMPACT
    • 4.2.1. HINDERANCE FROM GOVERNMENT REGULATIONS
    • 4.2.2. SMBG MANUFACTURERS RESTRAINING CGMS GROWTH
    • 4.2.3. INADEQUATE REIMBURSEMENT OPTIONS FOR CGM
    • 4.2.4. LACK OF KNOWLEDGE
  • 4.3. KEY TRENDS
    • 4.3.1. DEVELOPMENT OF HIGH-QUALITY WEARABLE DEVICES
    • 4.3.2. MOBILE HEALTHCARE MAKING THE DEVICES MORE USER-FRIENDLY
    • 4.3.3. INCREASING EFFORTS TOWARDS SPREAD OF AWARENESS
    • 4.3.4. INCREASE IN NON-INVASIVE DEVICES
    • 4.3.5. ENERGY HARVESTING TECHNOLOGY FOR UNINTERRUPTED USAGE

5. CGMS MARKET BY COMPONENT TYPE

  • 5.1. SENSORS
  • 5.2. TRANSMITTERS AND RECEIVERS
  • 5.3. INSULIN PUMP

6. CGMS MARKET BY APPLICATION

  • 6.1. HOME SETTINGS
  • 6.2. DIAGNOSTICS AND CLINICS
  • 6.3. HOSPITALS

7. SMBG MARKET

8. SMBG MARKET BY COMPONENT TYPE

  • 8.1. TEST STRIPS
  • 8.2. GLUCOSE METER
  • 8.3. OTHERS

9. SMBG MARKET BY APPLICATION

  • 9.1. HOME SETTINGS
  • 9.2. CLINICS
  • 9.3. HOSPITALS

10. KEY ANALYTICAL

  • 10.1. FORCES ANALYSIS
    • 10.1.1. THREAT OF NEW ENTRANT
    • 10.1.2. THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
    • 10.1.3. BARGAINING POWER OF BUYERS
    • 10.1.4. BARGAINING POWER OF SUPPLIER
    • 10.1.5. INTENSITY OF COMPETITIVE RIVALRY
  • 10.2. TOP THREE GEOGRAPHIES
  • 10.3. MERGER AND ACQUISITIONS

11. REGIONAL ANALYSIS

  • 11.1. NORTH AMERICA
    • 11.1.1. THE US
    • 11.1.2. CANADA
  • 11.2. EUROPE
    • 11.2.1. GERMANY
    • 11.2.2. THE UK
    • 11.2.3. FRANCE
    • 11.2.4. REST OF EUROPE (ROE)
  • 11.3. ASIA-PACIFIC (APAC)
    • 11.3.1. CHINA
    • 11.3.2. INDIA
    • 11.3.3. AUSTRALIA
    • 11.3.4. REST OF ASIA-PACIFIC (ROAP)
  • 11.4. LATIN AMERICA
  • 11.5. REST OF THE WORLD (ROW)

12. COMPETITIVE LANDSCAPE

  • 12.1. INTRODUCTION
  • 12.2. MEDTRONIC
    • 12.2.1. BUSINESS PROFILE
    • 12.2.2. PRODUCT PORTFOLIO
    • 12.2.3. REVENUE ANALYSIS
    • 12.2.4. STRATEGIC INPUTS
    • 12.2.5. SCOT ANALYSIS
  • 12.3. DEXCOM
    • 12.3.1. BUSINESS PROFILE
    • 12.3.2. PRODUCT PORTFOLIO
    • 12.3.3. REVENUE ANALYSIS
    • 12.3.4. STRATEGIC INPUTS
    • 12.3.5. SCOT ANALYSIS
  • 12.4. ABBOTT
    • 12.4.1. BUSINESS PROFILE
    • 12.4.2. PRODUCT PORTFOLIO
    • 12.4.3. REVENUE ANALYSIS
    • 12.4.4. STRATEGIC INPUTS
    • 12.4.5. SCOT ANALYSIS
  • 12.5. JOHNSON AND JOHNSON
    • 12.5.1. BUSINESS PROFILE
    • 12.5.2. PRODUCT PORTFOLIO
    • 12.5.3. REVENUE ANALYSIS
    • 12.5.4. STRATEGIC INPUTS
    • 12.5.5. SCOT ANALYSIS
  • 12.6. INSULET CORP
    • 12.6.1. BUSINESS PROFILE
    • 12.6.2. PRODUCT PORTFOLIO
    • 12.6.3. REVENUE ANALYSIS
    • 12.6.4. STRATEGIC INPUTS
    • 12.6.5. SCOT ANALYSIS
  • 12.7. TANDEM DIABETES CARE
    • 12.7.1. BUSINESS PROFILE
    • 12.7.2. REVENUE ANALYSIS
    • 12.7.3. PRODUCT PORTFOLIO
    • 12.7.4. STRATEGIES INPUTS
    • 12.7.5. SCOT ANALYSIS
  • 12.8. ECHO THERAPEUTICS INC
    • 12.8.1. BUSINESS PROFILE
    • 12.8.2. REVENUE ANALYSIS
    • 12.8.3. PRODUCT PORTFOLIO
    • 12.8.4. STRATEGIES INPUTS
    • 12.8.5. SCOT ANALYSIS
  • 12.9. ROCHE DIAGNOSTICS
    • 12.9.1. BUSINESS PROFILE
    • 12.9.2. REVENUE ANALYSIS
    • 12.9.3. PRODUCT PORTFOLIO
    • 12.9.4. STRATEGIES INPUTS
    • 12.9.5. SCOT ANALYSIS
  • 12.10. NEMAURA MEDICAL INC
    • 12.10.1. BUSINESS PROFILE
    • 12.10.2. REVENUE ANALYSIS
    • 12.10.3. PRODUCT PORTFOLIO
    • 12.10.4. STRATEGIES INPUTS
    • 12.10.5. SCOT ANALYSIS
  • 12.11. SENSEONICS INC
    • 12.11.1. BUSINESS PROFILE
    • 12.11.2. REVENUE ANALYSIS
    • 12.11.3. PRODUCT PORTFOLIO
    • 12.11.4. STRATEGIES INPUTS
    • 12.11.5. SCOT ANALYSIS
  • 12.12. GLYSENS INC
    • 12.12.1. BUSINESS PROFILE
    • 12.12.2. STRATEGIES INPUTS
    • 12.12.3. PRODUCT PORTFOLIO
    • 12.12.4. SCOT ANALYSIS

LIST OF TABLES

  • TABLE 1 GLOBAL CGMS MARKET BY GEOGRAPHY, 2017-2025(IN US$ MILLION)
  • TABLE 2 GLOBAL SMBG MARKET BY GEOGRAPHY, 2017-2025 (IN US$ MILLION)
  • TABLE 3 GLOBAL CGMS MARKET, BY COMPONENT TYPE, 2017-2025(IN US$ MILLION)
  • TABLE 4 GLOBAL CGMS SENSORS MARKET, 2017-2025(IN US$ MILLION)
  • TABLE 5 GLOBAL CGMS TRANSMITTERS AND RECEIVERS MARKET, 2017-2025(IN US$ MILLION)
  • TABLE 6 GLOBAL CGMS INSULIN PUMP MARKET, 2017-2025(IN US$ MILLION)
  • TABLE 7 GLOBAL CGMS MARKET, BY APPLICATION 2017-2025 (IN US$ MILLION)
  • TABLE 8 GLOBAL CGMS HOME SETTINGS MARKET, 2017-2025(IN US$ MILLION)
  • TABLE 9 GLOBAL CGMS DIAGNOSTICS AND CLINICAL MARKET, 2017-2025(IN US$ MILLION)
  • TABLE 10 GLOBAL CGMS HOSPITALS MARKET, 2017-2025(IN US$ MILLION)
  • TABLE 11 IMPORTANT ASPECTS FOR USE OF SMBG DEVICES IN HOME-CARE SETTINGS
  • TABLE 12 SMBG STRIPS USAGE SCENARIO IN SELECTED COUNTRIES IN AMERICA
  • TABLE 13 PRODUCT MATRIX FOR LANCETS
  • TABLE 14 GLOBAL SMBG MARKET, BY COMPONENT TYPE, 2017-2025 (IN US$ MILLION)
  • TABLE 15 GLOBAL SMBG MARKET 2017-2025 ($ MILLION)
  • TABLE 16 GLOBAL CGMS MARKET REVENUE, BY REGION, 2017-2025(IN US$ MILLION)
  • TABLE 17 GLOBAL SMBG MARKET REVENUE, BY REGION, 2017-2025(IN US$ MILLION)
  • TABLE 18 NORTH AMERICA SMBG MARKET 2017-2025 ($ MILLION)
  • TABLE 19 EUROPE SMBG MARKET 2017-2025 ($ MILLION)
  • TABLE 20 GERMANY DIABETIC STATISTICS 2015
  • TABLE 21 ASIA-PACIFIC SMBG MARKET 2017-2025(US$ MILLION)

LIST OF FIGURES

  • FIGURE 1 GLOBAL CGMS MARKET SHARE, BY COMPONENT TYPE 2016 & 2025 (%)
  • FIGURE 2 GLOBAL CGMS SENSORS MARKET, 2017-2025(IN US$ MILLION)
  • FIGURE 3 GLOBAL CGMS TRANSMITTERS AND RECEIVERS MARKET, 2017-2025(IN US$ MILLION)
  • FIGURE 4 GLOBAL CGMS INSULIN PUMP MARKET, 2017-2025(IN US$ MILLION)
  • FIGURE 5 GLOBAL CGMS SHARE, BY APPLICATION 2016 & 2025(%)
  • FIGURE 6 GLOBAL CGMS HOME SETTING MARKET, 2017-2025(IN US$ MILLION)
  • FIGURE 7 GLOBAL CGMS DIAGNOSTICS AND CLINICAL MARKET, 2017-2025(IN US$ MILLION)
  • FIGURE 8 GLOBAL CGMS HOSPITALS MARKET, 2017-2025(IN US$ MILLION)
  • FIGURE 9 GLOBAL SMBG MARKET SHARE, BY COMPONENT TYPE 2016 & 2025(%)
  • FIGURE 10 GLOBAL SMBG TEST STRIPS MARKET, 2017-2025 (IN US$ MILLION)
  • FIGURE 11 GLOBAL SMBG GLUCOSE METER MARKET, 2017-2025 (IN US$ MILLION)
  • FIGURE 12 GLOBAL SMBG OTHERS MARKET, 2017-2025 (IN US$ MILLION)
  • FIGURE 13 GLOBAL SMBG MARKET SHARE, BY COMPONENT TYPE 2016 & 2025(US$ MILLION)
  • FIGURE 14 GLOBAL SMBG HOME SETTING MARKET, 2017-2025 (IN US$ MILLION)
  • FIGURE 15 GLOBAL SMBG CLINICAL MARKET, 2017-2025 (IN US$ MILLION)
  • FIGURE 16GLOBAL SMBG HOSPITALS MARKET, 2017-2025 (IN US$ MILLION)
  • FIGURE 17 TOP THREE GEOGRAPHIES 2016
  • FIGURE 18 GLOBAL GGMS MARKET SHARE, BY GEOGRAPHY 2016 & 2025(%)
  • FIGURE 19 NORTH AMERICA CGMS MARKET SHARE, BY COUNTRY 2016 & 2025 (%)
  • FIGURE 20 US CGMS MARKET REVENUE, 2017-2025(IN USD MILLION)
  • FIGURE 21 US SMBG MARKET REVENUE, 2017-2025(IN USD MILLION)
  • FIGURE 22 CANADA CGMS MARKET REVENUE, 2017-2025 (IN USD MILLION)
  • FIGURE 23 CANADA SMBG MARKET REVENUE, 2017-2025 (IN USD MILLION)
  • FIGURE 24EUROPE CGMS MARKET SHARE, BY COUNTRY 2016& 2025 (%)
  • FIGURE 25 GERMANY CGMS MARKET REVENUE, 2017-2025(IN USD MILLION)
  • FIGURE 26 GERMANY SMBG MARKET REVENUE, 2017-2025(IN USD MILLION)
  • FIGURE 27 UK CGMS MARKET REVENUE, 2017-2025(IN USD MILLION)
  • FIGURE 28 UK SMBG MARKET REVENUE, 2017-2025(IN USD MILLION)
  • FIGURE 29 FRANCE CGMS MARKET REVENUE, 2017-2025(IN USD MILLION)
  • FIGURE 30 FRANCE SMBG MARKET REVENUE, 2017-2025(IN USD MILLION)
  • FIGURE 31 REST OF EUROPE (ROE) CGMS MARKET REVENUE, 2017-2025(IN USD MILLION)
  • FIGURE 32 REST OF EUROPE (ROE) SMBG MARKET REVENUE, 2017-2025(IN USD MILLION)
  • FIGURE 33 ASIA-PACIFIC CGMS MARKET REVENUE 2017-2025(US$ MILLION)
  • FIGURE 34 ASIA-PACIFIC CGMS MARKET SHARE, BY COUNTRY 2016 & 2025 (%)
  • FIGURE 35 CHINA CGMS MARKET REVENUE, 2017-2025(IN USD MILLION)
  • FIGURE 36 CHINA SMBG MARKET REVENUE, 2017-2025(IN USD MILLION)
  • FIGURE 37 INDIA CGMS MARKET REVENUE, 2017-2025(IN USD MILLION)
  • FIGURE 38 INDIA SMBG MARKET REVENUE, 2017-2025(IN USD MILLION)
  • FIGURE 39 AUSTRALIA CGMS MARKET REVENUE, 2017-2025(IN USD MILLION)
  • FIGURE 40 AUSTRALIA SMBG MARKET REVENUE, 2017-2025(IN USD MILLION)
  • FIGURE 41 REST OF ASIA-PACIFIC CGMS MARKET REVENUE, 2017-2025(IN USD MILLION)
  • FIGURE 42 REST OF ASIA-PACIFIC SMBG MARKET REVENUE, 2017-2025(IN USD MILLION)
  • FIGURE 43 LATIN AMERICA CGMS MARKET REVENUE, 2017-2025(IN USD MILLION)
  • FIGURE 44 LATIN AMERICA SMBG MARKET REVENUE, 2017-2025(IN USD MILLION)
  • FIGURE 45 ROW CGMS MARKET REVENUE, 2017-2025(IN USD MILLION)
  • FIGURE 46 ROW SMBG MARKET REVENUE, 2017-2025(IN USD MILLION)
Back to Top